Medios Investor Relations Material
Latest events
Q4 2023
Medios
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Medios AG
Access all reports
Medios AG is a Germany-based company that engages in the wholesale of specialty pharmaceutical drugs. It offers a range of products, such as Asacol, Dornase alfa, Doxil, Fludara, Flumadine, and Multiplix. The company distributes products to hospitals and other health care providers. It also provides pharmacy services in hospitals and other health care institutions. The company was founded in 2016 and is based in Berlin, Germany.
Key slides for Medios AG
Q4 2023
Medios AG
M&A Announcement
Medios AG
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇩🇪 Germany